EL SEGUNDO, Calif., Sept. 25, 2017 -- Griffin Capital Company, LLC (“Griffin Capital”) announced today that Griffin Capital Securities, LLC (“GCS”), Griffin Capital’s captive broker-dealer and distributor, completed a strategic realignment of its sales organization, a process that began in early 2017. “In an effort to better serve our broker-dealer partners and their financial advisors across our distribution channels, we reorganized our sales professionals into teams specifically focused on independent broker-dealers, registered investment advisors and wirehouse firms,” commented Mark Goldberg, CEO of GCS. “We believe ‘channelization’ is a more effective means by which to address the education and service needs of our advisor clients,” Goldberg continued.
In connection with the changes, Brady Gallagher, an industry veteran who has been with GCS for more than five years, was promoted to the position of Divisional Manager. “Brady is an outstanding wholesaler and a very valuable addition to our sales management team,” Goldberg added.
Pursuant to the sales team reorganization, GCS added new key sales team members. Effective today, GCS welcomes four new external wholesalers that will cover the IBD channel: Tom and John Dine in the Midwest territory, Alison Grant in the New England territory and Craig Arsenault in the Mid-Atlantic territory. “I am thrilled to be reunited with four great wholesalers – they each represent an outstanding addition to the Griffin team,” stated Goldberg.
Kevin A. Shields, Chairman and CEO of Griffin Capital, said, “I could not be more pleased with this important step forward. Today we are better positioned to further develop our alternative investment asset management platform as an unmatched leader in service and support to our partner firms, financial advisors and the clients they serve.”
About Griffin Capital Company, LLC
Griffin Capital is a leading alternative investment asset manager with approximately $9.5 billion* in assets under management. Founded in 1995, the privately-held firm is led by a seasoned team of senior executives with more than two decades of investment and real estate experience and who collectively have executed more than 650 transactions valued at over $22 billion. The firm manages, sponsors or co-sponsors a suite of carefully curated, institutional quality investment solutions distributed by Griffin Capital Securities, LLC to retail investors through a community of partners, including independent and insurance broker-dealers, wirehouses, registered investment advisory firms and the financial advisors who work with these enterprises.
Additional information available at www.griffincapital.com.*As of June 30, 2017.
Media Contacts
Jennifer Nahas
Vice President, Marketing
Griffin Capital Company, LLC
949-270-9332
[email protected]
Matthew Griffes/Joseph Kuo
Haven Tower Group LLC
424 652 6520, ext. 103 / 424 652 6520, ext 101
[email protected] or [email protected]


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



